细胞因子网络和心力衰竭结果:CA125作为堵塞和炎症之间的桥梁
Enrique Santas1,2, Arancha Martí-Martínez3, Sandra Villar1
1Cardiology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), 46010 Valencia, Spain.
International journal of molecular sciences
|October 16, 2025
概括
碳水化合物抗原125 (CA125) 水平影响心力衰竭 (HF) 的预后. 升高的CA125增强了与炎症标志物如IL-6和IL-10相关的风险,影响HF患者的死亡率和再住院.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 生物标志物研究 生物标志物研究
背景情况:
- 心力衰竭 (HF) 涉及炎症和拥堵.
- 碳水化合物抗原125 (CA125) 是一种已知的HF生物标志物,与拥堵有关.
- 此外,CA125可能会放大高血压患者的炎症反应.
研究的目的:
- 研究CA125对急性HF患者炎症的调节作用.
- 评估CA125,细胞因子 (IL-6,IL-10,IL-1β,TNF) 和临床结果之间的关系.
主要方法:
- 对284名急性HF患者进行前性研究.
- 在入院时测量CA125和细胞因子水平.
- 对所有原因死亡率和HF再住院的随访.
主要成果:
- 对于死亡率和再住院的IL-6,IL-10和CA125之间的显著相互作用 (p <0.05).
- 增加IL-6和IL-10与CA125>35U/mL的患者的风险增加相关.
- 在CA125 ≤35U/mL的患者中没有发现显著的关联.
结论:
- CA125状态显著调节IL-6,IL-10和高频率的不良结果之间的关联.
- 高CA125水平表明,当与IL-6和IL-10的升高相结合时,预后不佳.
- CA125可能在HF炎症中发挥功能作用.
相关概念视频
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
535
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
535
Myocarditis I: Introduction
368
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
368
Imbalances in Cardiac Output
2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Heart Failure I: Introduction
678
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
678

